Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Laboratorios Farmaceuticos Rovi SA Catalyst Calendar
Proactively evaluate Laboratorios Farmaceuticos Rovi SA’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Laboratorios Farmaceuticos Rovi SA Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 30 Jun 2022 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 01 May 2022 | Phase III Trial Completion | Enteromed Ltd; Frosst Iberica SA; Hangzhou Tigermed Consulting Co Ltd; Medpace Holdings Inc; PTC Therapeutics Inc | 300347; MEDP; PTCT | ataluren | Central Nervous System; Genetic Disorders; Musculoskeletal Disorders | Duchenne Muscular Dystrophy; Muscular Dystrophy; Neuromuscular Disorders; Unspecified Central Nervous System Disorders; Unspecified Genetic Disorders; Unspecified Musculoskeletal Disorders | Clinical Trial Registry |
| 31 Dec 2020 | NDA/BLA Filing (US) | Laboratorios Farmaceuticos Rovi SA | ROVI | risperidone PR | Central Nervous System | Schizophrenia | Company Presentation |
| 31 Mar 2020 | MAA Filing (EU) | Laboratorios Farmaceuticos Rovi SA | ROVI | risperidone PR | Central Nervous System | Schizophrenia | Company Presentation |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer